Side-by-side comparison of AI visibility scores, market position, and capabilities
NASDAQ-listed (PRPL) DTC sleep brand with Hyper-Elastic Polymer grid mattresses for pressure relief and temperature regulation; $480M revenue competing with Tempur-Sealy and Sleep Number for premium mattress.
Purple Innovation is a Lehi, Utah-based sleep products company — publicly listed on NASDAQ (NASDAQ: PRPL) — manufacturing and selling mattresses, pillows, cushions, and bedding under the Purple brand, built around the proprietary Hyper-Elastic Polymer grid technology that provides pressure relief, temperature regulation, and responsive support without the heat retention of traditional memory foam. Founded in 2015 by Tony Pearce and Terry Pearce (inventors with foam manufacturing background) and IPO'd via SPAC merger in 2018, Purple generated approximately $480 million in revenue in fiscal year 2024 serving sleep-focused consumers through DTC e-commerce, showrooms, and retail partners including Mattress Firm and Bloomingdale's.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.